AtriCure (NASDAQ:ATRC – Free Report) had its target price decreased by JPMorgan Chase & Co. from $51.00 to $46.00 in a ...

Canaccord lowered the firm’s price target on AtriCure (ATRC) to $52 from $66 and keeps a Buy rating on the shares. The firm updated its model ...

Shaping Responsible Governance of AI and Emerging Technologies in a Future Digital Economy The Advanced Technology Research ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Atricure (ATRC – Research Report) and Journey ...

Barclays said in a note Monday that it sees attractive entry points in MedTech stocks, as recent weakness in some sector ...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Monday - March 24 ...

AtriCure, Inc. (NASDAQ:ATRC – Get Free Report)’s stock price passed above its two hundred day moving average during trading on Friday .The stock has a two hundred day moving average of $33.37 ...

U.S. stock futures point higher after markets plunged yesterday on recession worries; airline stocks decline sharply after Delta Air Lines (DAL) cut its sales and earnings guidance; Oracle (ORCL ...

Tesla stock has crashed in recent months, down 55% from its mid-December high. Investors are concerned about CEO Elon Musk's time commitment to the company. "It's become clear he's now spending ...

U.S. stock futures point lower after a volatile week of trading and President Donald Trump's comments from a weekend interview in which he failed to rule out a recession; Oracle (ORCL) shares are ...

The stock finally dropped into free fall today, plunging more than 15 percent to mark one of the company’s worst trading days since it went public in 2010. The tumble erased the last vestiges of ...